Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-03 · accession 0001628280-25-004088 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-05 | 2025-02-03 | RXRX | Taylor Ben R | CFO | F - Tax | $7.25 | -6,544 | 886.6K | -0.7% | -$47.4K |
| DM | 2025-02-05 | 2025-02-03 | RXRX | Taylor Ben R | CFO | A - Grant | $0.00 | +48.9K | 879.2K | +6% | $0 |
| D | 2025-02-05 | 2025-02-03 | RXRX | Taylor Ben R | CFO | A - Grant | $0.00 | +70.0K | 70.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-03 | F | D | 6,544 | $7.25 | 886,606 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-02-03 | A | A | 13,922 | $0.00 | 893,150 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-02-03 | A | A | 35,018 | $0.00 | 879,228 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | A | A | 70,037 | $0.00 | 70,037 | D | $7.25 · — to 2035-02-03 | 70,037 Class A Common Stock | (F4) The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. |